Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults-Reference-Cited by-同舟云学术

Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults

Published:2017-04-25 Issue:1 Volume:178 Page:106-111
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Arai Yasuyuki¹²,Kondo Tadakazu¹^ORCID,Shigematsu Akio³,Tanaka Junji⁴,Ohashi Kazuteru⁵,Fukuda Takahiro⁶,Kawakita Toshiro⁷,Mori Takehiko⁸,Hoshino Takumi⁹^ORCID,Onizuka Makoto¹⁰,Ozawa Yukiyasu¹¹,Yoshida Shuro¹²,Ueda Yasunori¹³,Mizuno Ishikazu¹⁴,Atsuta Yoshiko¹⁵¹⁶,Mizuta Shuichi¹⁷,

Affiliation:

1. Department of Haematology and Oncology; Graduate School of Medicine; Kyoto University; Kyoto Japan

2. Laboratory of Host Defences; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Bethesda MD USA

3. Department of Haematology; Sapporo Hokuyu Hospital; Sapporo Japan

4. Department of Haematology; Tokyo Women's Medical University; Tokyo Japan

5. Haematology Division; Tokyo Metropolitan Cancer and Infectious Diseases Centre; Komagome Hospital; Tokyo Japan

6. Department of Haematopoietic Stem Cell Transplantation; National Cancer Centre Hospital; Tokyo Japan

7. Department of Haematology; National Hospital Organization Kumamoto Medical Centre; Kumamoto Japan

8. Division of Haematology; Department of Medicine; Keio University School of Medicine; Tokyo Japan

9. Leukaemia Research Centre; Saiseikai Maebashi Hospital; Maebashi Japan

10. Department of Haematology/Oncology; Tokai University School of Medicine; Isehara Japan

11. Department of Haematology; Japanese Red Cross Nagoya First Hospital; Nagoya Japan

12. Department of Haematology; Hamanomachi Hospital; Fukuoka Japan

13. Department of Haematology/Oncology and Transfusion and Haemapheresis Centre; Kurashiki Central Hospital; Kurashiki Japan

14. Department of Haematology; Hyogo Cancer Centre; Akashi Japan

15. Japanese Data Centre for Haematopoietic Cell Transplantation; Nagoya Japan

16. Department of Healthcare Administration; Nagoya University Graduate School of Medicine; Nagoya Japan

17. Department of Haematology; National Hospital Organization Toyohashi Medical Centre; Toyohashi Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14652/fullpdf

Reference12 articles.

1. Risk factors for and prognosis of hemorrhagic cystitis after allogeneic stem cell transplantation: retrospective analysis in a single institution;Arai;Hematology,2012

2. Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy;Arai;Blood,2015

3. High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study;Arai;Bone Marrow Transplantation,2016

4. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System;Atsuta;International Journal of Hematology,2007

5. Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence;Besien;American Society of Hematology Education Program,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensified conditioning regimens improved disease‐free survival and engraftment after unrelated single‐unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation;Hematological Oncology;2022-10-31

2. Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI;Hematological Oncology;2022-07-10

3. Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation;International Journal of Hematology;2021-03-01

4. Conditioning regimen of single-unit cord blood transplantation for hematological malignancy;Japanese Journal of Transplantation and Cellular Therapy;2021

5. Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine/cyclophosphamide/total body irradiation with versus without G-CSF priming: G-CONCORD study protocol;BMJ Open;2020-12